Anna French, D.Phil., is a Managing Partner at Qiming Venture Partners USA (qimingvc.com). She joined Qiming in 2017 from the Boston Consulting Group, where she advised leading pharma and biotech companies on strategy and operations with a focus on cell therapy and regenerative medicine. Previously, she led the CASMI Translational Stem Cell Consortium, a partnership of Oxford University and UCL advancing the translation of scientific innovation. Anna holds a D.Phil. from the University of Oxford, has authored 20+ publications in stem cell research, and earned a first-class BSc in Biochemistry from the University of Bristol. LinkedIn: https://www.linkedin.com/in/annafrenchvc.